Synairgen Plc Financials
| SNG Stock | 4.39 0.31 6.60% |
EPS Estimate Current Year (0.03) | Return On Equity (0.49) |
Synairgen | Select Account or Indicator |
Please note, the presentation of Synairgen Plc's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Synairgen Plc's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Synairgen Plc's management manipulating its earnings.
Synairgen Plc Stock Summary
Synairgen Plc competes with Bank of Ireland, BE Semiconductor, Cincinnati Financial, UNIQA Insurance, and Take Two. Synairgen Plc is entity of United Kingdom. It is traded as Stock on LSE exchange.| Foreign Associate | USA |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | UK Stock View All |
| Exchange | London Exchange |
| ISIN | GB00B0381Z20 |
| Business Address | Mailpoint 810, Southampton, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.synairgen.com |
| Phone | 44 23 8051 2800 |
You should never invest in Synairgen Plc without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Synairgen Stock, because this is throwing your money away. Analyzing the key information contained in Synairgen Plc's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Synairgen Plc Key Financial Ratios
There are many critical financial ratios that Synairgen Plc's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Synairgen plc reports annually and quarterly.| Gross Profit | 105 K | ||||
| EBITDA | (9.57 M) | ||||
| Net Income | (8.41 M) | ||||
| Total Asset | 14.22 M | ||||
| Retained Earnings | (115.08 M) |
Synairgen Plc Key Balance Sheet Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 4.1M | 88.5M | 44.6M | 23.5M | 14.2M | 12.7M | |
| Other Current Liab | 1.2M | 1.5M | 3.1M | 2.5M | 792K | 846.7K | |
| Net Debt | (2.1M) | (74.8M) | (33.8M) | (15.9M) | (10.5M) | (11.0M) | |
| Retained Earnings | (27.1M) | (42.1M) | (90.3M) | (107.0M) | (115.1M) | (109.3M) | |
| Cash | 2.5M | 75.0M | 33.8M | 15.9M | 10.5M | 8.3M | |
| Other Current Assets | 1.0M | 13.1M | 10.6M | 3.7M | 2.1M | 2.0M | |
| Total Liab | 1.8M | 3.4M | 7.6M | 3.3M | 1.6M | 1.2M | |
| Total Current Assets | 3.5M | 88.2M | 44.4M | 23.4M | 14.1M | 12.5M | |
| Intangible Assets | 29.0 | 16K | 44K | 53K | 102K | 71.1K | |
| Common Stock | 1.1M | 2.0M | 2.0M | 2.0M | 2.0M | 2.1M | |
| Accounts Payable | 161K | 1.5M | 4.2M | 548K | 592K | 545.9K | |
| Net Receivables | 1.0M | 13.1M | 10.6M | 3.7M | 2.1M | 2.3M | |
| Net Tangible Assets | 2.2M | 85.1M | 36.9M | 20.2M | 23.3M | 19.7M | |
| Net Invested Capital | 2.3M | 85.1M | 37M | 20.3M | 12.7M | 12.0M | |
| Net Working Capital | 1.8M | 84.8M | 36.8M | 20.1M | 12.5M | 11.9M |
Synairgen Plc Key Income Statement Accounts
An income statement is very similar to a cash flow statement, but instead of showing net revenue minus expenses, it only includes earnings before interest and taxes (EBIT). This number does not have all of the same line items that are on a cash flow statement, but it leaves out non-cash expenses like depreciation and amortization. For example, if you bought $100 worth of goods from Walmart (WMT) using your debit card that has an interest rate of 20%, then paid off the balance at the end of the month with a credit card that charges 30% interest, you would have an income statement showing EBIT of $80 because your expenses are lower than the amount that went into your pocket.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Interest Expense | 6K | 10K | 2K | 207K | 186.3K | 195.6K | |
| Gross Profit | (163K) | (260K) | (195K) | (102K) | (84K) | (79.8K) | |
| Operating Income | (4.8M) | (17.7M) | (57.9M) | (20.3M) | (10.3M) | (10.8M) | |
| Ebit | (4.8M) | (17.7M) | (57.9M) | (20.1M) | (9.7M) | (10.1M) | |
| Research Development | 3.4M | 15.5M | 52.8M | 14.9M | 6.5M | 6.1M | |
| Ebitda | (4.6M) | (17.5M) | (57.7M) | (20.0M) | (9.6M) | (10.1M) | |
| Cost Of Revenue | 163K | 260K | 195K | 102K | 84K | 76.1K | |
| Income Before Tax | (4.8M) | (17.7M) | (57.9M) | (20.1M) | (9.7M) | (10.1M) | |
| Net Income | (3.9M) | (13.9M) | (48.7M) | (17.6M) | (8.4M) | (8.8M) | |
| Income Tax Expense | (908K) | (3.8M) | (9.2M) | (2.4M) | (1.2M) | (1.3M) | |
| Tax Provision | (908K) | (3.8M) | (9.2M) | (2.4M) | (1.2M) | (1.3M) | |
| Net Interest Income | 36K | 24K | 9K | 207K | 635K | 666.8K | |
| Interest Income | 30K | 19K | 11K | 207K | 635K | 666.8K |
Synairgen Plc Key Cash Accounts
Cash flow analysis captures how much money flows into and out of Synairgen plc. It measures of how well Synairgen is doing because it can show the actual money that comes into and out of the Company from sales instead of measuring expenses against revenue to determine earnings. You have to read the cash flow statement in three sections. The first section shows how much money Synairgen Plc brought in, usually known as net revenue or sales. This is different from earnings because it does not include expenses when determining net revenue for use on this part of the cash flow statement. Next, are operating activities, which show how much money Synairgen had leftover after paying for its expenses. This number can be calculated in two ways: by subtracting the total of all operating expenses from net revenue or by adding up changes to cash and other assets or liabilities on this part of the statement. The third section is about investing activities, which shows what Synairgen Plc has done with the money that it received from the sale of assets or what it spent to acquire new ones. This section can be broken down into two parts: investing in existing businesses (in other words, buying more stock) and investing in non-business activities like paying off debt or making acquisitions.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | (2.8M) | 72.5M | (41.1M) | (17.9M) | (5.4M) | (5.1M) | |
| Free Cash Flow | (2.9M) | (23.9M) | (41.0M) | (14.2M) | (8.3M) | (8.7M) | |
| Depreciation | 163K | 260K | 195K | 102K | 84K | 77.6K | |
| Other Non Cash Items | (440K) | 5.3M | (16.6M) | 7.4M | 531K | 557.6K | |
| Capital Expenditures | 10K | 76K | 33K | 6K | 13K | 12.4K | |
| Investments | 50K | (45K) | (21K) | (3.6M) | 2.8M | 3.0M | |
| Change To Netincome | 17K | (2.7M) | (4.8M) | 7.4M | 8.5M | 8.9M |
Synairgen Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Synairgen Plc's current stock value. Our valuation model uses many indicators to compare Synairgen Plc value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Synairgen Plc competition to find correlations between indicators driving Synairgen Plc's intrinsic value. More Info.Synairgen plc is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Synairgen Plc's earnings, one of the primary drivers of an investment's value.Synairgen plc Systematic Risk
Synairgen Plc's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Synairgen Plc volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on Synairgen plc correlated with the market. If Beta is less than 0 Synairgen Plc generally moves in the opposite direction as compared to the market. If Synairgen Plc Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Synairgen plc is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Synairgen Plc is generally in the same direction as the market. If Beta > 1 Synairgen Plc moves generally in the same direction as, but more than the movement of the benchmark.
Synairgen plc Total Assets Over Time
Synairgen Plc December 4, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Synairgen Plc help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Synairgen plc. We use our internally-developed statistical techniques to arrive at the intrinsic value of Synairgen plc based on widely used predictive technical indicators. In general, we focus on analyzing Synairgen Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Synairgen Plc's daily price indicators and compare them against related drivers.
| Information Ratio | (0.08) | |||
| Maximum Drawdown | 30.99 | |||
| Value At Risk | (9.79) | |||
| Potential Upside | 10.56 |
Complementary Tools for Synairgen Stock analysis
When running Synairgen Plc's price analysis, check to measure Synairgen Plc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Synairgen Plc is operating at the current time. Most of Synairgen Plc's value examination focuses on studying past and present price action to predict the probability of Synairgen Plc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Synairgen Plc's price. Additionally, you may evaluate how the addition of Synairgen Plc to your portfolios can decrease your overall portfolio volatility.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| CEOs Directory Screen CEOs from public companies around the world |